Vivo Capital Fund VIII, L.P.'s Net Worth

$55.6 Million

Who is Vivo Capital Fund VIII, L.P.?

Vivo Capital Fund VIII, L.P. has an estimated net worth of $55.6 Million. This is based on reported shares across multiple companies, which include Crinetics Pharmaceuticals, Inc., Menlo Therapeutics Inc., Aligos Therapeutics, Inc., Terns Pharmaceuticals, Inc., IMPEL NEUROPHARMA INC, Bolt Biotherapeutics, Inc., Kadmon Holdings, Inc., and BioPharmX Corp.

SEC CIK

Vivo Capital Fund VIII, L.P.'s CIK is 0001618788

Past Insider Trading and Trends

2021 was Vivo Capital Fund VIII, L.P.'s most active year for acquiring shares with 33 total transactions. Vivo Capital Fund VIII, L.P.'s most active month to acquire stocks was the month of January. 2020 was Vivo Capital Fund VIII, L.P.'s most active year for disposing of shares, totalling 37 transactions. Vivo Capital Fund VIII, L.P.'s most active month to dispose stocks was the month of January. 2021 saw Vivo Capital Fund VIII, L.P. paying a total of $25,074,158.33 for 9,490,040 shares, this is the most they've acquired in one year. In 2019 Vivo Capital Fund VIII, L.P. cashed out on 417,000 shares for a total of $9,278,250.00, their largest year based on trade value.